OAKTREE CAPITAL MANAGEMENT LP
Position in BTAI — BioXcel Therapeutics, Inc.
CIK 949509
LOS ANGELES, CA
Position in BTAI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,946,149
+$1,622,958 QoQ
Shares Held
1,380,248
+472.3% QoQ
Ownership
4.41%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2
of 46 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OAKTREE CAPITAL MANAGEMENT LP holds $253,707,210 across 3 Drug Manufacturers - Specialty & Generic names. BTAI ranks #2 (0.8% of the industry book) .
All Filings in BTAI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,946,149 | 1,380,248 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $323,191 | 241,188 | Shares | Defined | 2026-05-20 | |
| 2025-12-31 | $385,900 | 241,188 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $617,441 | 241,188 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $436,550 | 241,188 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||